List of GLP-1 Drugs
List of GLP-1 drugs: the 12 brand-name GLP-1 labels in this chart, by brand and by medicine. People also call them GLP-1 medications or GLP-1 meds.
Paste this code into your page. It shows the GLP-1 comparison chart with one plain credit link.
Learn
More about this page
We read each label on DailyMed on October 6, 2026 and used the newest version listed that day. Each row gives that label's version and date and links to it.
Every brand label, newest version on DailyMed
| Brand | Medicine | Type | Maker | Taken as | Label version |
|---|---|---|---|---|---|
| Ozempic | semaglutide | GLP-1 | Novo Nordisk | Injection (pen or prefilled syringe) | v20, June 1, 2026 |
| Wegovy | semaglutide | GLP-1 | Novo Nordisk | Injection (pen or syringe); Tablet | v19, June 18, 2026 |
| Rybelsus and Ozempic tablets | semaglutide | GLP-1 | Novo Nordisk | Tablet | v14, January 30, 2026 |
| Mounjaro | tirzepatide | GIP and GLP-1 | Eli Lilly | Injection (pen or vial) | v40, August 27, 2026 |
| Zepbound | tirzepatide | GIP and GLP-1 | Eli Lilly | Injection (pen or vial) | v40, August 28, 2026 |
| Foundayo | orforglipron | GLP-1 | Eli Lilly | Tablet | v10, July 29, 2026 |
| Saxenda | liraglutide | GLP-1 | Novo Nordisk | Injection (pen) | v22, February 25, 2026 |
| Victoza | liraglutide | GLP-1 | Novo Nordisk | Injection (pen) | v31, October 14, 2025 |
| Trulicity | dulaglutide | GLP-1 | Eli Lilly | Injection (pen) | v62, June 16, 2026 |
| ByettaDrugs@FDA: discontinued | exenatide | GLP-1 | AstraZeneca | Injection (pen) | v26, September 2, 2025 |
| Xultophy | insulin degludec and liraglutide | Insulin plus GLP-1 | Novo Nordisk | Injection (pen) | v14, October 14, 2025 |
| Soliqua | insulin glargine and lixisenatide | Insulin plus GLP-1 | Sanofi | Injection (pen) | v25, March 18, 2026 |
Rybelsus and Ozempic tablets share one label. Wegovy shots and Wegovy tablets also share one label. To put any 3 of them side by side, open the GLP-1 comparison chart.
GLP-1 drugs by medicine
A brand is the name on the box. The medicine is the molecule inside. Several brands can hold the same medicine.
- Semaglutide: Ozempic, Wegovy, Rybelsus, Ozempic tablets.
- Tirzepatide: Mounjaro, Zepbound. Its labels call it a GIP and GLP-1 receptor agonist.
- Liraglutide: Saxenda and Victoza. Xultophy mixes it with an insulin.
- Dulaglutide: Trulicity.
- Exenatide: Byetta. It is no longer marketed in the US. On September 3, 2025, the FDA withdrew its approval, as the maker had asked. Its last label is still on DailyMed. A generic exenatide from Amneal has its own label.
- Orforglipron: Foundayo, a tablet first approved in 2026.
- Lixisenatide: Soliqua mixes it with an insulin.
To see two of these next to each other, try Ozempic vs Wegovy or tirzepatide vs semaglutide.
Types of GLP-1 drugs
You can sort these medicines in three ways, using facts from their labels.
- By target. Most act on the GLP-1 receptor only. Tirzepatide acts on the GIP and GLP-1 receptors. In this chart it is the only medicine that also acts on GIP.
- By form. Most are shots under the skin. Wegovy tablets, Rybelsus, Ozempic tablets and Foundayo are tablets. See the GLP-1 pill page.
- By use. Some labels are for blood sugar in type 2 diabetes. Some are for excess body weight. In this chart, the labels that list weight loss as a use are Wegovy, Zepbound, Saxenda and Foundayo. Some list more than one use.
How each one acts is on the page how do GLP-1 drugs work.
Generic GLP-1 drugs
Some GLP-1 medicines also have generic labels. The FDA approves a generic through a short form of drug application, called an ANDA. We counted generic labels in the openFDA label database on October 7, 2026.
| Medicine | Generic labels (ANDA) | Makers | Makers named on those labels |
|---|---|---|---|
| semaglutide | 0 | 0 | |
| tirzepatide | 0 | 0 | |
| liraglutide | 14 | 9 | Biocon Pharma Inc., Cipla USA Inc., Hikma Pharmaceuticals USA Inc., Hybio Pharmaceutical Co., Ltd. (Pingshan Factory), Lupin Pharmaceuticals, Inc., Meitheal Pharmaceuticals Inc., NorthStar Rx LLC, Orbicular Pharmaceutical Technologies Private Limited, Teva Pharmaceuticals, Inc. |
| dulaglutide | 0 | 0 | |
| exenatide | 1 | 1 | Amneal Pharmaceuticals LLC |
| orforglipron | 0 | 0 | |
| lixisenatide | 0 | 0 |
The chart on this site lists the brand labels only. Each generic label names its own maker.
Brands with no label on DailyMed
We searched DailyMed for two older brands and found no label for either. Drugs@FDA still lists both by name.
| Brand | Medicine | DailyMed search, October 6, 2026 | Drugs@FDA status |
|---|---|---|---|
| Bydureon BCise | exenatide | 0 labels found | NDA209210: discontinued |
| Adlyxin | lixisenatide | 0 labels found | BLA208471: prescription |
Questions
What is the generic name for Ozempic?
Semaglutide. The Ozempic label names semaglutide as the medicine. Wegovy and Rybelsus contain semaglutide too.
What are GLP-1 receptor agonists?
GLP-1 receptor agonists are medicines that turn on the GLP-1 receptor, the same way the body's own GLP-1 hormone does. That hormone comes from the gut. A 2018 review explains that it helps control blood sugar and food intake. Every label on this list uses the name. Some also name GIP or insulin.
Are there generic GLP-1 drugs?
Yes, for two of them. On October 7, 2026, openFDA listed generic (ANDA) labels for liraglutide and exenatide only. It listed none for semaglutide, tirzepatide, dulaglutide, orforglipron or lixisenatide. A DailyMed search for those five names the same day found only brand labels.
Who makes GLP-1 drugs?
The brand labels on this list name four makers. They are Novo Nordisk, Eli Lilly, AstraZeneca and Sanofi. Generic labels name other makers.
What are the types of GLP-1 drugs?
You can group them by target, form and use. Most act on GLP-1 only, and tirzepatide acts on GIP and GLP-1. Most are shots, and three labels cover tablets.
How many GLP-1 drugs are there?
This chart has 12 brand-name GLP-1 labels. Counting each medicine once, they hold 7 GLP-1 medicines: semaglutide, tirzepatide, liraglutide, dulaglutide, exenatide, orforglipron and lixisenatide. Two of the labels, Xultophy and Soliqua, mix one of these with an insulin.
Sources
17 sources with read dates
- Ozempic label on DailyMed, Novo Nordisk, version 20 of 2026-06-01, read 2026-10-06
- Wegovy label on DailyMed, Novo Nordisk, version 19 of 2026-06-18, read 2026-10-06
- Rybelsus and Ozempic tablets label on DailyMed, Novo Nordisk, version 14 of 2026-01-30, read 2026-10-06
- Mounjaro label on DailyMed, Eli Lilly, version 40 of 2026-08-27, read 2026-10-06
- Zepbound label on DailyMed, Eli Lilly, version 40 of 2026-08-28, read 2026-10-06
- Foundayo label on DailyMed, Eli Lilly, version 10 of 2026-07-29, read 2026-10-06
- Saxenda label on DailyMed, Novo Nordisk, version 22 of 2026-02-25, read 2026-10-06
- Victoza label on DailyMed, Novo Nordisk, version 31 of 2025-10-14, read 2026-10-06
- Trulicity label on DailyMed, Eli Lilly, version 62 of 2026-06-16, read 2026-10-06
- Byetta label on DailyMed, AstraZeneca, version 26 of 2025-09-02, read 2026-10-06
- Xultophy label on DailyMed, Novo Nordisk, version 14 of 2025-10-14, read 2026-10-06
- Soliqua label on DailyMed, Sanofi, version 25 of 2026-03-18, read 2026-10-06
- openFDA drug label API, US Food and Drug Administration, generic labels with an ANDA number for all seven medicines, read 2026-10-07
- DailyMed web services, label search by drug name, National Library of Medicine, search for the five medicines with no generic label, read 2026-10-07
- Abbreviated New Drug Application (ANDA), US Food and Drug Administration, read 2026-10-06
- Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1, Drucker DJ, Cell Metabolism 2018, PMID 29617641, abstract read on PubMed 2026-10-06
- Drugs@FDA application records, US Food and Drug Administration, via the openFDA drugsfda API, read 2026-10-06